본문 바로가기

Early response evaluation of doxorubicin-nanoparticle-microbubble therapy in orthotopic hepatocellular carcinoma rat model using contrast-enhanced ultrasound and intravoxel incoherent motion-diffusion MRI

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q1KCI Q1
저널
ULTRASONOGRAPHY41(1) · pp.150 · 2022
피인용
Web of Science 5Scopus 5KCI 0
FWCI (Scopus)
0.47
JCR IF
JCR 2021 4.725
ISSN
2288-5919

저자

  1. Yang, Hyun Kyung제1저자Yonsei Univ, Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea
  2. Kim, Jung Hoon교신저자Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea
  3. Lee, Hak JongSeoul Natl Univ, Dept Radiol, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea
  4. Moon, HyungwonIMGT Co Ltd, Seongnam, South Korea
  5. 류화성Pusan Natl Univ, Dept Radiol, Yangsan Hosp, Yangsan, South Korea
  6. Han, Joon KooSeoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea

초록

Purpose: This study aimed to apply doxorubicin-loaded nanoparticle microbubble (Dox-NP-MB) therapy in an orthotopic rat model of hepatocellular carcinoma (HCC) and investigate the utility of contrast-enhanced ultrasound ( CEUS) and intravoxel incoherent motion diffusion-weighted magnetic resonance imaging (IVIM-DWI) for response evaluation. Methods: Twenty-eight N1S1 HCC model rats were treated with either Dox-NP-MB (group [G] 1, n=8), doxorubicin (Dox) alone (G2, n=7), nanoparticle microbubbles alone ( G3, n=7), or saline (G4, control, n=6) on days 0 and 7, and were sacrificed on day 11. IVIM-DWI and CEUS were performed before each treatment and before euthanasia. Efficacy was estimated by the percentage of tumor volume growth inhibition compared with control. Toxicity was assessed by body weight changes and blood tests. Post-treatment changes in IVIM-DWI and CEUS parameters were analyzed. Results: Tumor volume growth was inhibited by 48.4% and 90.2% in G1 and G2 compared to G4, respectively. Compared to G2, G1 had a significantly lower degree of body weight change (median, 91.0% [interquartile range, 88.5%-97.0%] vs. 88.0% [82.5%-88.8%], P<0.05) and leukopenia (1.75x10(3) cells/mu L [1.53-2.77] vs. 1.20x10(3) cells/mu L [0.89-1.51], P<0.05). After the first treatment, an increase in peak enhancement, wash-in rate, and wash-in perfusion index on CEUS was observed in G3 and G4 but suppressed in G1 and G2; the apparent diffusion coefficients, true diffusion coefficients, and perfusion fractions significantly increased in G1 and G2 compared to baseline (P<0.05). Conclusion: Dox-NP-MB showed reduced Dox toxicity. Early changes in some CEUS and IVIM-DWI parameters correlated with the therapeutic response.

키워드

Hepatocellular carcinomaTheranostic nanomedicineAnimal modelsUltrasonographyDiffusion magnetic resonance imagingDELIVERYUPDATEPHARMACODYNAMICSREPRODUCIBILITYGUIDELINESUSCT

식별자

Scopus EID
2-s2.0-85122153970
WoS UID
000735403400014
KCI
ART002794098